
The results from Diabetic Retinopathy Clinical Research Network protocols have become the standard of care for treating DME and proliferative diabetic retinopathy.

The results from Diabetic Retinopathy Clinical Research Network protocols have become the standard of care for treating DME and proliferative diabetic retinopathy.

Ophthalmologists can opt to use vital stains for cultures and corneal scrapings.

Studies highlight need for specialists and training programs focusing on the disease

Physician provides contemporary perspective and pearls to guide ophthalmologists.

Protocol V delves into observation of disease.

Women 34% less likely to receive retinal detachment repair.

Physicians step-up in emergency departments during COVID-19 surge.

Investigators reviewing options that include bifocals, low-dose atropine drops

Treatment of patients with COVID-19 should include ophthalmic considerations.

Organization works to ensure clinical care and access for high-risk patients.

Community involvement, research continue to boost treatment in pediatric population.

Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.

Spaceflight-associated neuro-ocular syndrome a potential challenge during long missions.

A novel ocular corticosteroid is offering hope of quick results for patients.

Preeya Gupta, MD, discusses the results of a study evaluating the safety and efficacy of KPI-121 0.25% for the treatment of dry eye disease.

Improvements gained prior to surgery can result in positive outcomes.

Protocol T Extension Study details methods needed to maintain VA gains over time.

Ehsan Rahimy, MD, speaks on the highlights of a study he presented at this year's virtual AAO 2020 meeting that aimed to integrate an artificial intelligence screening system for managing diabetic retinopathy referrals in a primary care setting — with limited specialty support.

Programs use detection and treatment to ease burden of eye disease.

DME diagnosis plays no role in determining whether patients will receive injection.

New paradigm-changing treatments for young patients on the horizon.

Investigators research safety, efficacy of endolaserless vitrectomy.

Using active learning approach can help gauge visual function loss in patients

Researchers evaluate effects of procedure on patients with abnormal topography

Watchful waiting may prove to be beneficial in complicated cases